The George Institute for Global Health India today hosted a showcase of its SMARThealth technology, designed to help community health workers identify and treat people at high risk of chronic conditions such as diabetes and heart disease.
On September 19 2018, the ‘Salt Substitute and Stroke Study (SSaSS) Annual Meeting 2018’ was held in Qingdao. Over 50 participants joined the meeting to review progress on the study and exchange experiences. Those who attended the meeting included Principal Investigators from China and Australia, Project Coordinators from provincial study centers, and government officials from local Disease Control and Prevention Centers and Public Health Systems.
New research has found that long-term exposure to high blood pressure is associated with an increased risk of aortic valve disease, with significant implications for clinical practice guidelines and health management.
The number of people with sepsis in Australian intensive care units (ICUs) is 50% higher than previously reported. The report from Royal North Shore Hospital and The George Institute for Global Health also found death rates for sepsis had been underestimated by 10%, with around a third of patients with sepsis in ICUs losing their lives.
Making provision for free treatment under a publicly funded dialysis program allows more people with advanced kidney failure to access this expensive treatment but is not able to address all barriers to ensure long-term success, reveals a new study by The George Institute for Global Health, India.
A new low dose three in one pill to treat hypertension could transform the way high blood pressure is treated around the world.
A trial led by The George Institute for Global Health revealed that most patients – 70 per cent – reached blood pressure targets with the ‘Triple Pill’, compared to just over half receiving normal care.